Biogen/Elan delay release of Phase III Antegren data

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Biogen/Elan delay release of Phase III Antegren data

Postby Xenova » Thu Aug 19, 2004 11:04 am

BIOGEN IDEC, ELAN TO DELAY RELEASE OF PHASE III ANTEGREN DATA UNTIL RECEIPT OF APPROVAL FROM FDA

This is probably not a major development. They are still on course to get it approved at the end of the year in the US. The article does mention that there is speculation that this might be a sign that an antegren/avonex combination study is not yielding desired results.


http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=115017
User avatar
Xenova
Family Member
 
Posts: 71
Joined: Thu May 20, 2004 2:00 pm
Location: Louisiana, USA

Advertisement

Postby Nemotoday » Mon Aug 23, 2004 7:08 am

An interesting post, but the link is down.

Kindest regards to all 8O
User avatar
Nemotoday
Family Member
 
Posts: 72
Joined: Fri May 21, 2004 2:00 pm

Postby Arron » Mon Aug 23, 2004 9:32 am

Nemo: This is covered on the front page as well...
User avatar
Arron
Volunteer Moderator
 
Posts: 892
Joined: Sun Feb 01, 2004 3:00 pm
Location: California, USA

Postby Nemotoday » Tue Aug 24, 2004 1:32 am

Thanks, I was hoping that the link might give little more detail.

Take care
User avatar
Nemotoday
Family Member
 
Posts: 72
Joined: Fri May 21, 2004 2:00 pm

Antegren Study Patient

Postby ELMO » Mon Nov 01, 2004 4:15 pm

I'm a first time poster to this or any other MS related forum.

I'm writting on behalf of my younger 26 year old sister, diagnosted with having MS.

We are trying to get information on any published Antegren study results.

Here's her story.

Being a seemingly healthy person, with no prior medical conditions, she was diagnosed with MS in 2001. She was approached by her neurologist to participate in a Natalizumab study (Biogen Protocol Number C-1801) at St. Micheal's Hospital, in Toronto, Ontario. She was on the drug for over one year. One night she experienced what she thought was a relapse of MS. Several months ago, she called the doctor & hospital with hours of experience MS-like symptoms. They told her not to worry for at least 24 hours. That night she suffered a debilitating stroke.

After seeing the neuroligist, they opened her study files and confirmed that she was in fact part of the study group being receiving Natalizumab.

She was assured by the neurologist (who is the primary investigator for study) that this was not a result of the drug. However, she was immediately removed from the study. None of the doctors, specialists that were called in to investigate her case could provide an explaination as to why a 26 woman, with no blood, heart problems suffered this stroke. Based on the seemingly evasive requests for information and fact that other medical specialists involved in the study were aware of the fact this had occured to her, we question whether this was ever reported.

Is there anywhere we can go to see the results of these studies? Would this type of thing be reported anywhere that we could verify?

Thanks for any help
ELMO
 

Postby Arron » Mon Nov 01, 2004 7:00 pm

Elmo, thank you for sharing your story. Please register for the site and send me a private message...
User avatar
Arron
Volunteer Moderator
 
Posts: 892
Joined: Sun Feb 01, 2004 3:00 pm
Location: California, USA

Postby Bob-B » Thu Dec 30, 2004 10:01 am

:D
Hello all.......I'm new to this site. So far I like what I see. It just so happens that my wife and I met with her neurologist yesterday and discussed Tysabri. An informational letter from Biogen Eldec stated that the companies findings, in regards to the phase III study data, should be ready for release around May, 2005. BB
User avatar
Bob-B
Newbie
 
Posts: 1
Joined: Wed Dec 29, 2004 3:00 pm


Return to Tysabri (Antegren or Natalizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service

cron